Previous 10 | Next 10 |
The following slide deck was published by PolarityTE, Inc. in conjunction with their 2020 Q1 earnings Read more ...
PolarityTE, Inc. (Nasdaq: PTE) , a biotechnology company developing regenerative tissue products and biomaterials, today reported financial results for the first calendar quarter of 2020. PolarityTE will host a conference call and webcast today, May 11, 2020 at 8:00 a.m. ET. Highlights ...
Axcella Health (NASDAQ: AXLA ) initiated with Buy rating and $10 (115% upside) price target at BTIG Research. More news on: Axcella Health Inc., Viking Therapeutics, Inc., Y-mAbs Therapeutics, Inc., Healthcare stocks news, Stocks on the move, Read more ...
PolarityTE, Inc. (Nasdaq: PTE) is providing an update on a change to the strategic focus of the Company and the regulatory pathway for the Company’s SkinTE™ product. PolarityTE has decided to pursue a plan to submit an investigational new drug application (IND) and thereaf...
PolarityTE (NASDAQ: PTE ) provides corporate update and preliminary Q1 2020 results. More news on: PolarityTE, Inc., Healthcare stocks news, , Read more ...
PolarityTE, Inc. (Nasdaq: PTE) , a biotechnology company developing and commercializing regenerative tissue products and biomaterials, is providing an update on actions the Company is taking to best position the business and support the Company’s stakeholders in light of the COVID-19 ...
PolarityTE, Inc. (Nasdaq: PTE) , a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today announced that data from its Head-to-Head Burn trial was published in the Journal of Burn Care & Research . This abstract was accepted for a podiu...
PolarityTE, Inc. (Nasdaq: PTE) , a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today announced that it has received correspondence from the United States Securities and Exchange Commission (“SEC”) advising PolarityTE that ...
PolarityTE, Inc. (Nasdaq: PTE) , a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today announced the appointment of Chris Nolet to the Company’s Board of Directors and Chair of the Audit Committee. Mr. Nolet brings extensive audit ...
Aimed at establishing a more traditional management structure, PolarityTE (NASDAQ: PTE ) has dissolved the Office of the Chief Executive and appointed David Seabury as CEO while COO Richard Hague will also serve as President. More news on: PolarityTE, Inc., Healthcare stocks news, Stocks...
News, Short Squeeze, Breakout and More Instantly...
(TheNewswire) Mississauga, ON - TheNewswire - M ay 30 , 202 3 - Pioneering Technology Corp. ( TSXV:PTE ) (“ Pioneering ” or the “ Company ”), a technology company and North America’s l...
(TheNewswire) Mississauga, ON – TheNewswire - May 5, 2023 - Pioneering Technology Corp. (“ Pioneering ” or the “ Company ”) (TSXV:PTE) , a technology company and North America's leader in cooking fire prevention technolo...
(TheNewswire) Mississauga, ON - TheNewswire - March 1, 2023 - Pioneering Technology Corp. ( TSXV:PTE ) (“ Pioneering ” or the “ Company ”), a technology company and North America’s leader in cooking fire prevention t...